Parallel secures $20M to transform hospital administration with AI
Paris-based healthtech startup Parallel has raised $20 million in fresh funding from leading venture firm Index Ventures, aiming to reduce hospital administrative workloads by up to 30% through advanced AI automation.
The investment underscores growing investor confidence in AI-driven healthcare operations, as hospitals worldwide struggle with staff shortages, rising costs and mounting paperwork that keeps clinicians away from patients.
AI platform targets paperwork overload in hospitals
Parallel develops software that uses AI algorithms and natural language processing to automate routine, time-consuming tasks such as patient intake, documentation, billing preparation and data entry into electronic health records. By integrating directly with hospital IT systems, the platform is designed to streamline workflows without forcing clinicians to change their core tools.
The company claims its technology can cut administrative time by around 30% for targeted processes, freeing doctors and nurses to focus more on direct patient care. The solution also aims to reduce human error in documentation and improve the quality and completeness of clinical records, which are critical for both care outcomes and reimbursement.
Backing from Index Ventures to scale across Europe
With the new capital from Index Ventures, Parallel plans to accelerate product development, strengthen its data security and compliance capabilities, and expand commercial operations across Europe. The startup is expected to invest heavily in interoperability with major electronic health record platforms and in building trust with hospital administrators and clinicians.
The funding round reflects a broader shift in healthcare, where hospital leaders are increasingly looking to AI-powered workflow tools to tackle burnout, improve operational efficiency and manage tightening budgets. As health systems continue to digitise, solutions like Parallel‘s are positioned to become a core layer of the hospital back office, quietly handling administrative work in the background while clinicians stay at the bedside.
For investors, the deal highlights the growing attractiveness of healthtech companies that address systemic inefficiencies rather than only clinical diagnostics or treatment.